Acute Porphyria Drug Database

Monograph

A10AE56 - Insulin Degludec and Liraglutide
Propably not porphyrinogenic
PNP

Rationale
Combination of two substances classified as NP (insulin degludec) and PNP (liraglutide). For more extensive monographs, please search the individual substances insulin degludec (ATC A10AE06) and liraglutide (A10BX07).
Chemical description
Liraglutide is a human glucagon-like peptide-1 analog, with a 97 per cent sequence homology to the human hormone. Insulin degludec is an antidiabetic pancreatic hormone consisting of two polypeptide chains, A and B, connected by two diulphide bridges.
Similar drugs
Explore alternative drugs in similar therapeutic classes A10A / A10AE or go back.
Tradenames
This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.


Xultophy Xultophy Xultophy Xultophy Xultophy Xultophy Xultophy Xultophy Xultophy Xultophy Xultophy Xultophy Xultophy Xultophy
 
© NAPOS 2025
An unhandled error has occurred. Reload 🗙